Announcements and Notices - [Very Substantial Acquisition / Issue of Shares under a Specific Mandate / Consideration Issue / Reverse Takeover / Announcement by Offeree Company under the Takeovers Code / Connected Transaction / Change of Company Name / Capital Reorganisation / Share Scheme / Other - Miscellaneous]

Genor Biopharma Holdings Ltd operates as a biopharmaceutical company. The Company focuses on developing and commercializing oncology and autoimmune drugs. Genor Biopharma Holdings serves customers worldwide.

(1) Very Substantial Acquisition And Connected Transaction Involving Issue Of Consideration Shares Under Specific Mandate; (2) Reverse Takeover Involving The New Listing Application; (3) Application For Whitewash Waiver; (4) Special Deal; (5) Proposed Change Of Company Name; (6) Proposed Increase In Authorised Share Capital Of The Company; And (7) Proposed Adoption Of The One-Off Share Option Plan; And Despatch Of Circular

Announcements and Notices - [Closure of Books or Change of Book Closure Period]

Closure Of Register Of Members

Documents On Display

Announcements and Notices - [Notice of EGM/SGM]

Notice Of Extraordinary General Meeting

Form Of Proxy For The Extraordinary General Meeting To Be Held At Room 501-02, 5/F, Building 6, 690 Bibo Road, Pudong New District, Shanghai, China On Monday, 22 December 2025 At 10: 00 A.M.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00